Eye News and Research

Latest Eye News and Research

Rising number of asthma deaths in Australia: Study

According to a study by the Australian Institute of Health and Welfare the number of people over 45 dying from asthma attacks has increased in the past five years. In 2006 402 people had died of asthma. 2005 had only 318 deaths related to asthma in comparison. 2006 saw a 40 percent hike from the preceding three years says the report.

19 May 2010

Plastic corneal prosthesis for patients unable to tolerate donor corneas

For many patients who become blind after an accident or illness, a corneal transplantation could restore the ability to see. Each year, 40,000 people in Europe - in Germany, about 7,000 - await the opportunity to be able to see again, thanks to cornea donors. But donor corneas are not common. Dr. Joachim Storsberg of the Fraunhofer Institute for Applied Polymer Research IAP in Potsdam-Golm developed material and production process for a corneal prosthesis made of plastic.

19 May 2010

People with asthma or COPD at risk from oil-dispersing chemicals

Oil washing ashore and the chemicals used in the clean up may pose a health risk for those who have respiratory diseases according to an environmental allergy-asthma expert.

19 May 2010

Neuro Kinetics releases new version of VEST control and analysis software

Neuro Kinetics, Inc., manufacturers of noninvasive medical diagnostic equipment used worldwide to test for neuro-otologic, vestibular and neurological dysfunctions, said today that it has released version 6.8 of its VEST control and analysis software.

19 May 2010

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced the pricing of its previously announced underwritten public offering of 11,500,000 units of its securities at a public offering price of $0.41 per unit.

19 May 2010

International Stem Cell announces strategic alliance with TAP

International Stem Cell Corporation, www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership, www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue.

18 May 2010

China Sky One Medical first-quarter total revenues increase 16.4% to $28.9 million

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced record financial results for the first quarter of 2010. Management is working diligently to finalize the amended Annual Report on Form 10-K for 2009.

18 May 2010

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.

18 May 2010

Dehaier Medical Systems becomes exclusive China distributor of Welch Allyn's patient monitors

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical products in China, said today that it has become the exclusive China distributor of Welch Allyn's patient monitors.

17 May 2010

Tufts University's School of Arts and Sciences receives $9.5M grant to create research space

Tufts University's School of Arts and Sciences has received a $9.5 million grant to create research space that will house a Collaborative Cluster in Genome Structure and Developmental Patterning in Health and Disease.

17 May 2010

Early CPAP as effective for preemies as ventilator, with fewer complications: Study

Two findings from an NIH research network study provide new information on how much oxygen very preterm infants should receive starting on the first day of life and the most effective means to deliver it to them.

17 May 2010

Better health care for the indigenous population

A report from Melbourne University says that Indigenous Australians are six times more likely than other Australians to be blind and more than a third of this population has never had an eye examination. Now a substantial number of optometrists will be sent to remote Aboriginal communities under a $6.5 million federal program.

16 May 2010

Soliant Health opens up voting for 20 Most Beautiful Hospitals contest

Soliant Health, a leading specialty healthcare staffing provider and part of Adecco Group, has opened up voting for its second annual 20 Most Beautiful Hospitals contest.

15 May 2010

Twenty rising juniors to create bras during summer break

Students at the celebrated Otis College of Art and Design in Los Angeles will contribute decorated bras from the school's design competition for Chesapeake Regional Medical Center's 3rd annual October Bra-ha-ha.

15 May 2010

Lotus Pharmaceuticals first-quarter net income up 38%

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported its financial results for the first quarter ended March 31, 2010.

15 May 2010

Data from RGN-259 study published in Archives of Ophthalmology

RegeneRx Biopharmaceuticals, Inc. announced today the publication of the first human data from a case study of patients evaluated with its ophthalmic product candidate RGN-259. The data have been published in the May 2010 issue of Archives of Ophthalmology, an American Medical Association peer-reviewed journal.

14 May 2010

FDA Advisory Committee planned to review Lux Biosciences' NDA for voclosporin

Isotechnika Pharma Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration is scheduled to review partner, Lux Biosciences', New Drug Application for voclosporin on June 28, 2010.

13 May 2010

Study: Treating serious gum disease in diabetics can help lower blood sugar levels

Researchers have found that reducing inflammation of the gums in people with diabetes can help lower the risk of serious complications associated with the condition, such as eye problems and heart disease.

13 May 2010

Computerized systems can detect early eye problems related to diabetes: UI team

People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems.

13 May 2010

pSivida reports consolidated net loss of $2.7 million for third-quarter 2010

pSivida Corp., a drug delivery company with two of the only three ophthalmic sustained release delivery products approved by the FDA for treatment of back-of-the-eye diseases, today announced financial results for its third quarter and nine months ended March 31, 2010.

13 May 2010